Study of Transverse Abdominis Plane (TAP) Block in Children Undergoing Hydrocelectomy and/or Hernia Repair Surgery

NCT ID: NCT01698268

Last Updated: 2017-08-24

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-02-29

Study Completion Date

2014-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Study measures the difference in pain after hernia \&/or hydrocele repair based on site of local anesthesia injection.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This single-center, prospective, single blind, randomized study will enroll up to 50 subjects who are scheduled for elective hydrocelectomy and/or hernia repair. At Beaumont Health System, post-operative pain management in children is managed either via oral/parenteral opiates and opiate adjuncts, surgeon-administered field blocks (instillation of local anesthetics in the general area of incision), or via regional techniques (spinal, epidural, or peripheral nerve blocks). We have designed this study to determine if there is improved qualitative and quantitative post-operative pain control in patients receiving TAP block versus intraoperative peri-incisional, surgeon administered field block. Once informed consent has been given, each patient will be randomized (like flip of the coin) to either Transverse Abdominis Plane Block (TAP Block)or surgeon administered anesthesia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hydrocele Inguinal Hernia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TAP Group

Enrolled subjects will receive a TAP block with 0.5cc/kg of 0.25% ropivacaine.

Group Type EXPERIMENTAL

TAP block

Intervention Type PROCEDURE

TAP Block will be performed under ultrasound guidance via Sonosite device with an in-plane technique by the anesthesiologist.

Local Infiltration Group

Enrolled subjects will receive will receive local infiltration of 0.5 cc/kg of 0.25% ropivacaine.

Group Type ACTIVE_COMPARATOR

Local Infiltration

Intervention Type PROCEDURE

Local infiltration of 0.5 cc/kg of 0.25% ropivacaine will be administered by the surgeon.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

TAP block

TAP Block will be performed under ultrasound guidance via Sonosite device with an in-plane technique by the anesthesiologist.

Intervention Type PROCEDURE

Local Infiltration

Local infiltration of 0.5 cc/kg of 0.25% ropivacaine will be administered by the surgeon.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children 2-8 years of age
* Elective inguinal hernia repair, inguinal hernia repair with peritoneoscopy and/or hydrocelectomy to be performed in the Center for Children's Surgery, Beaumont Hospital, Royal Oak
* American Society of Anesthesiologists physical status classification 1 and 2 (patients that have either no systemic illness, or mild systemic disease that is well controlled, eg. mild asthma)

Exclusion Criteria

* History of allergy to study medications
* Enrollment in concurrent research study
* Pregnant patients\*
* Students/trainees/staff\*
* Mentally disabled/cognitively impaired\*
Minimum Eligible Age

2 Years

Maximum Eligible Age

8 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kaveh Aslani, MD

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kaveh Aslani, MD

Principal Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kaveh Aslani, MD

Role: PRINCIPAL_INVESTIGATOR

Beaumont Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Beaumont Health System

Royal Oak, Michigan, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2011-213

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.